← Back to Search

Self-help guided by a lay provider for Generalized Anxiety Disorder

N/A
Waitlist Available
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post treatment (15 weeks), 6 months and 12 months follow-up.
Awards & highlights

Study Summary

This trial is testing whether psychological self-help guided by a lay provider is an effective treatment for Generalized Anxiety Disorder in older adults, compared to waiting to receive treatment.

Eligible Conditions
  • Generalized Anxiety Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post treatment (15 weeks), 6 months and 12 months follow-up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post treatment (15 weeks), 6 months and 12 months follow-up. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in GAD-7
Change in Penn State Worry Questionnaire
Secondary outcome measures
Change in Cognitive Avoidance Questionnaire
Change in GAD diagnosis
Change in Geriatric Anxiety Inventory
+7 more
Other outcome measures
Evaluation of treatment by participants
Nine items relating to COVID-19
Questionnaire of behavioral manifestations linked to anxiety

Trial Design

2Treatment groups
Experimental Treatment
Group I: Waiting list where participants wait for delayed treatmentExperimental Treatment2 Interventions
Group II: Self-help guided by a lay providerExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Self-help guided by a lay provider
2019
N/A
~150
Waiting list where participants wait for delayed treatment
2019
N/A
~150

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
417 Previous Clinical Trials
172,122 Total Patients Enrolled
1 Trials studying Generalized Anxiety Disorder
3,610 Patients Enrolled for Generalized Anxiety Disorder
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,343 Previous Clinical Trials
26,452,943 Total Patients Enrolled
9 Trials studying Generalized Anxiety Disorder
4,763 Patients Enrolled for Generalized Anxiety Disorder
CIUSSS du Centre-Sud-de-l'Île-MontréalUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this trial still ongoing?

"Unfortunately, the posted data on clinicaltrials.gov reveals that this research project is not presently recruiting patients; however, there are currently 414 other trials actively seeking participants. This trial was first listed on March 11th 2019 and last modified January 3rd 2022."

Answered by AI

What are the intended outcomes of this experiment?

"Across a Baseline, post-treatment (15 weeks), 6 months, and 12 months follow-up time frame, this trial's primary goal is to measure Generalized Anxiety Disorder 7 (GAD-7). Secondary measures include the Why Worry Questionnaire (25 items rated on a 1 to 5 scale with higher scores associated with more use of worrying as an effective tool), Intolerance to Uncertainty Inventory (27 items on a 1 to 5 scale where higher totals suggest greater aversion towards uncertainty), and Cognitive Avoidance Questionnaire (25 questions ranked from 1 - 5 indicating tendencies for cognitive avoidance)."

Answered by AI
~25 spots leftby Apr 2025